| Literature DB >> 33935984 |
Tatiana Amabile de Campos1,2, Felipe Marques de Almeida3, Ana Paula Cardoso de Almeida2, Rafael Nakamura-Silva4, Mariana Oliveira-Silva4, Isabela Felix Alencar de Sousa3, Louise Cerdeira5,6, Nilton Lincopan6, Georgios Joannis Pappas1,3, André Pitondo-Silva4,7.
Abstract
Klebsiella variicola is mainly associated with opportunistic infections and frequently identified as Klebsiella pneumoniae. This misidentification implies a wrong epidemiology result as well as incorrect attribution to K. pneumoniae as the etiology of some severe infections. Recently, huge efforts have been made to study K. variicola, however, the biological aspects of this species are still unclear. Here we characterized five K. variicola strains initially identified as K. pneumoniae, with a Vitek-2 System and 16S rRNA sequencing. One-step multiplex polymerase chain reaction and Whole Genome Sequencing (WGS) identified them as K. variicola. Additionally, WGS analysis showed that all the strains are closely related with K. variicola genomes, forming a clustered group, apart from K. pneumoniae and K. quasipneumoniae. Multilocus sequence typing analysis showed four different sequence types (STs) among the strains and for two of them (Kv97 and Kv104) the same ST was assigned. All strains were multidrug-resistant (MDR) and three showed virulence phenotypes including invasion capacity to epithelial cells, and survival in human blood and serum. These results showed the emergence of new K. variicola clones with pathogenic potential to colonize and cause infection in different tissues. These characteristics associated with MDR strains raise great concern for human health.Entities:
Keywords: Klebsiella variicola; antimicrobial resistance; brazilian clones; multidrug-resistant; pathogenicity; whole genome sequence
Year: 2021 PMID: 33935984 PMCID: PMC8085564 DOI: 10.3389/fmicb.2021.604031
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Isolation data, biofilm production, hypermucousviscous phenotype and antimicrobial resistance profile of Klebsiella variicola strains.
| Strain ID | Culture | Patient data | Isolation period (year-month) | Hmv | Biofilm production | Antimicrobial resistance profile* | |
| Genera | Birth date (year-month) | ||||||
| Kv15 | Urine | F | 1942/Aug | 2015/Apr | − | STR | MDR (tobramycin, doxycycline, nitrofurantoin, tetracycline, sulfonamide, trimethoprim + sulfamethoxazole, trimethoprim, nalidixic acid) |
| Kv35 | Blood | F | 1973/Sept | 2015/Sept | − | W | MDR (ciprofloxacin, tobramycin, cefuroxime, nitrofurantoin, sulphonamide, trimethoprim + sulfamethoxazole, trimethoprim, nalidixic acid) |
| Kv57 | Catheter | M | 1961/Sept | 2016/Mar | − | M | MDR (tobramycin, doxycycline, nitrofurantoin, sulphonamide, trimethoprim + sulfamethoxazole, trimethoprim) |
| Kv97 | Urine | F | 1940/Mar | 2017/Jan | + | STR | MDR (ciprofloxacin, tobramycin, nitrofurantoin, sulphonamide, trimethoprim + sulfamethoxazole, trimethoprim) |
| Kv104 | Blood | F | 1959/Aug | 2017/Jan | + | STR | MDR (ciprofloxacin, tobramycin, nitrofurantoin, sulphonamide, trimethoprim + sulfamethoxazole, trimethoprim) |
FIGURE 1Biological assays used to determine the pathogenic potential of Klebsiella variicola strains. (A) Bacterial survival after incubation in human blood for different times at 37°C. (B) Bacterial survival after incubation in human serum for different times at 37°C. (C) Bacterial invasion in HEp-2 cells. (D) Bacterial cytotoxicity to HEp-2 cells. The bacterial survival was determined by CFU counting of strains plated from the incubation in blood and serum. Bacterial invasion was determined by CFU counting of strains plated after HEp-2 lysis. Cytotoxicity to HEp-2 cells were determined by the Griss Method. All assays were performed in triplicate. ANOVA one-way were used for statical analysis, *p < 0.05 values were considered significant.
Antimicrobial resistance genes (ARG), virulence genes (VG), and molecular typing of Klebsiella variicola strains.
| Strain ID | ARG | K | O | VG | ST |
| Kv15 | KL60 | O3 | Capsule, enterobactin, type 1 fimbriae, type3 fimbriae, | 170 | |
| Kv35 | KL71 | O3 | Capsule, enterobactin, Type 1 fimbriae, Type3 fimbriae, | 171 | |
| Kv57 | KL111 | O3 | Capsule, enterobactin, type 1 fimbriae, type3 fimbriae, | 168 | |
| Kv97 | KL20 | O3 | Capsule, enterobactin, type 1 fimbriae, type3 fimbriae, | 172 | |
| Kv104 | KL20 | O3 | Capsule, enterobactin, type 1 fimbriae, typ3 fimbriae, | 172 |
FIGURE 2Tree representation of the genetic relationships among the different profiles of the K. variicola MLST scheme, produced via GrapeTree with the minimum spanning tree algorithm (MSTree V2). The STs identified in this study are shown with a red arrow. For readability purposes, all the genomes that were the only representant of a country were removed.
FIGURE 3Distribution of K. pneumoniae virulence factors among K. variicola genomes, represented in a presence/absence matrix of genes. The genomes have been clustered based on their gene content.
The closest genome to each of Klebsiella variicola strains isolated in Brasilia, DF, Brazil, based on the absolute values of genome distances.
| Strain | Closest genome | Genetic distance | Institution | Geographic location |
| Kv15 | GCF_003197065.1 | 0.006174 | Washington university | United States: St. Louis, Missouri |
| Kv35 | GCF_003195165.1 | 0.006569 | Washington university | United States: St. Louis, Missouri |
| Kv57 | GCF_900509865.1 | 0.004744 | Wellcome sanger institute | Belgium |
| *Kv97 and Kv104 | GCF_003285185.1 | 0.006857 | Beijing institute of microbiology and epidemiology | China: Zhejiang |